Invention Grant
- Patent Title: Heterocyclylamines as PI3K inhibitors
-
Application No.: US15673529Application Date: 2017-08-10
-
Publication No.: US10092570B2Publication Date: 2018-10-09
- Inventor: Yun-Long Li , Wenqing Yao , Andrew P. Combs , Eddy W. Yue , Song Mei , Wenyu Zhu , Joseph Glenn , Thomas P. Maduskuie, Jr. , Richard B. Sparks , Brent Douty , Chunhong He
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; A61K31/519 ; C07D519/00
Abstract:
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Public/Granted literature
- US20170340641A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS Public/Granted day:2017-11-30
Information query
